MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-PB-03-0012892
Redinex Life Sciences Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.26 Cr
▲ 33% YoY
Net profit · FY 2025
₹11.91 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹78.51 Lakh
EBITDA margin 9.5%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹3.26 Cr
Satisfied ₹99 Lakh
Company age
8 yrs
Est. 2018
Directors on board
4
As per MCA filings
About Redinex Life Sciences Private Limited
Data last updated:
Redinex Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC340121. Its GSTIN is 03AAJCR1877Q1ZQ (Punjab).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Karan Deep Garg and Romi Bansal.
Its last annual general meeting (AGM) was held on 28 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Second Floor Cw – 234, Pvt Shop No 2 Sanjay Gandhi Transport Nagar, Delhi, India – 110042.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.26 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹11.91 Lakh (net margin 1.4%) and EBITDA of ₹78.51 Lakh (EBITDA margin 9.5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
As per MCA filings, the company has open charges of ₹3.26 Cr and satisfied charges of ₹99 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.
Redinex Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-03-0012892). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website redinexlifesciences.com.
Company details
CIN U74999DL2018PTC340121
Registration Number 340121
Incorporation Date 05 October 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PB-03-0012892
Recognitions & Rankings of Redinex Life Sciences
Contact details
Redinex Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is redinexlifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSecond Floor Cw – 234, Pvt Shop No 2 Sanjay Gandhi Transport Nagar, Delhi, India – 110042
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Redinex Life Sciences Private Limited, buy the company report.
Comprehensive company report
Redinex Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Redinex Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Redinex Life Sciences Private Limited, buy the company report.
Financials of Redinex Life Sciences Private Limited
FY 2025 filings availableRedinex Life Sciences Private Limited reported revenue of ₹8.26 Cr (up 33% YoY) for FY 2025.
Revenue · FY 2025
₹8.26 Cr ▲ 33%
Net profit · FY 2025
₹11.91 Lakh margin 1.4%
EBITDA · FY 2025
₹78.51 Lakh margin 9.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 53%
3 years · compounded
▲ 4%
5 years · compounded
▲ 125%
Revenue has grown at a compounded annual rate (CAGR) of 11% over three years, including 33% growth in the latest year. EBITDA rose 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹78.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Redinex Life Sciences Private Limited, buy the company report.
Board of directors of Redinex Life Sciences Private Limited
Redinex Life Sciences has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karan Deep Garg | Director | 14 Jul 2022 | 4 Years 3 Months | Current |
| Romi Bansal Also directs: Kenford Lifescience Private Limited | Director | 05 Oct 2018 | 8 Years 1 Months | Current |
| Gurdit Singh | Additional Director | 07 Mar 2025 | 1 Years 8 Months | Current |
| Meva Singh | Director | 23 Jul 2025 | 1 Years 3 Months | Current |
Peer comparison
Redinex Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sterlife Biotech Private Limited | ₹8.32 Cr (FY 2025) | 17.0% | Ahmedabad, Gujarat, India | |||
| Arogya Formulations Private Limited | ₹8.29 Cr (FY 2024) | 45.0% | Delhi, India | |||
| Redinex Life Sciences Private Limitedthis company | ₹8.26 Cr (FY 2025) | ₹11.91 Lakh | 1.4% | 33.0% | Delhi, India | |
| Jhanil Healthcare Private Limited | ₹8.18 Cr (FY 2024) | 59.0% | Sunam, Punjab, India | |||
| Swasthya Vardhak Pharmacy Private Limited | ₹8.12 Cr (FY 2024) | -1.0% | Varanasi, Uttar Pradesh, India |
To see the full peer comparison of Redinex Life Sciences Private Limited, buy the company report.
Auditor
Redinex Life Sciences Private Limited is audited by SHIV JINDAL & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHIV JINDAL & CO | FY 2023 | 011316N |
Shareholding
The shareholding of Redinex Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Redinex Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.26 Cr
Satisfied charges
₹99 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Dec 2023 | 100856170 | Others | ₹16 Lakh | Open | |
| 08 Dec 2022 | 100660190 | Others | ₹3.1 Cr | Open | |
| 30 Aug 2019 | 100289422 | Others | ₹64 Lakh | Satisfied | |
| 30 Aug 2019 | 100289421 | Others | ₹35 Lakh | Satisfied |
To see the full charge records of Redinex Life Sciences Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Redinex Life Sciences Private Limited has 3 court cases on record: 3 filed against it. All cases are pending.
Total cases
3
Filed against the company
3
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Virbac Animal Health India Pvt. Ltd. | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Virbac Animal Health India Pvt. Ltd. | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Virbac Animal Health India Pvt. Ltd. | Pending |
To see the full case history of Redinex Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Redinex Life Sciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 4 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Naksha Pharmaceuticals Private Limited | |||
| an individual supplier | |||
| Jain Pharma Traders and Agencies LLP |
To see the full MSME payment records of Redinex Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Redinex Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAJCR1877Q1ZQ | Punjab | Active | 07 Nov 2018 |
To see the full GST registrations and return filing status of Redinex Life Sciences Private Limited, buy the company report.
Recent activity
Redinex Life Sciences Private Limited has 9 board changes on record since 2018: 4 appointments and 5 cessations. The latest: Meva Singh ceased to be Additional Director on 27 Sep 2025.
AGM
Redinex Life Sciences Private Limited last Annual general meeting of members was held on 28 Sep 2025 as per latest MCA records.
Ceased
Meva Singh ceased to be Additional Director.
Ceased
Gurdit Singh ceased to be Additional Director.
Appointed
Meva Singh was appointed as Director.
Filing
Redinex Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Gurdit Singh was appointed as Additional Director.
Ceased
Karan Deep Garg ceased to be Director.
Charges
A charge with Others of Rs. 310.00 Lakh registered on 08 Dec 2022 with Charge ID 100660190 was modified on 20 Aug 2024.
Charges
A charge with Others amounted to Rs. 16.00 Lakh with Charge ID 100856170 was registered on 13 Dec 2023.
Charges
A charge registered on 30 Aug 2019 via Charge ID 100289421 with Others was fully satisfied on 06 Apr 2023.
Charges
A charge registered on 30 Aug 2019 via Charge ID 100289422 with Others was fully satisfied on 30 Mar 2023.
Charges
A charge with Others amounted to Rs. 310.00 Lakh with Charge ID 100660190 was registered on 08 Dec 2022.
7 earlier events are in the company report.
Frequently asked questions
Redinex Life Sciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 October 2018 (8+ years old) and is registered under CIN U74999DL2018PTC340121.
Redinex Life Sciences has 4 current directors:
- Karan Deep Garg - Director
- Romi Bansal - Director
- Gurdit Singh - Additional Director
- Meva Singh - Director
The latest financial statements of Redinex Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Redinex Life Sciences is 03AAJCR1877Q1ZQ, registered in Punjab.
The CIN (Corporate Identification Number) of Redinex Life Sciences is U74999DL2018PTC340121. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Redinex Life Sciences has 3 court cases on record: 3 filed against it. 3 are pending.
Redinex Life Sciences was incorporated on 05 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Redinex Life Sciences by revenue are Sterlife Biotech Private Limited, Arogya Formulations Private Limited, Jhanil Healthcare Private Limited, Swasthya Vardhak Pharmacy Private Limited, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Meva Singh ceased to be Additional Director on 27 Sep 2025. Gurdit Singh ceased to be Additional Director on 23 Jul 2025. Meva Singh was appointed as Director on 23 Jul 2025. Redinex Life Sciences has 9 board changes on record in total.
Yes, Redinex Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-PB-03-0012892).
Redinex Life Sciences has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 4 overdue payments to 4 micro and small suppliers. The latest return was filed on 02 May 2024.
Redinex Life Sciences can be reached through the website redinexlifesciences.com. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages